Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9606752 | 0.63 | KDM4E (0.41) | KDM4E | |
| SCHEMBL7758239 | 0.58 | KDM4E (0.38) | KDM4E | |
| SCHEMBL31041484 | 0.56 | KDM4E (0.33) | KDM4E | |
| SCHEMBL13259344 | 0.56 | BRD4 (0.31) | KDM4E | |
| SCHEMBL14214190 | 0.55 | KDM4E (0.36) | KDM4E | |
| SCHEMBL31707825 | 0.55 | KDM4E (0.36) | KDM4E | |
| SCHEMBL4442902 | 0.54 | MB (0.33) | KDM4E | |
| SCHEMBL10843176 | 0.54 | MB (0.33) | KDM4E | |
| SCHEMBL31041481 | 0.54 | LMNA (0.48) | KDM4E | |
| SCHEMBL19056384 | 0.54 | BRD4 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005090356-A1 | 1,3 DIHYDROFURO [3,4-c]PYRIDINES AND THEIR PREPARATION | DSM IP ASSETS B.V. (NL) | 2005-09-29 | — | — | WO | disclosed |
| US-20040242885-A1 | Manufacture of vitamin b6 | DSM IP ASSETS B.V. (NL) | 2004-12-02 | — | — | US | disclosed |
| EP-1430062-A2 | MANUFACTURE OF VITAMIN B6 | DSM IP Assets B.V. (NL) | 2004-06-23 | — | — | EP | disclosed |
| WO-2003027121-A2 | MANUFACTURE OF VITAMIN B6 | DSM IP ASSETS B.V. (NL) | 2003-04-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040242885-A1 | Manufacture of vitamin b6 | LIG1, LIG3, LIG4 | KDM4E 581/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.